Canaccord Genuity Limited Form 8.5 (EPT/RI) - MedicX Fund Limited (8924S)

TIDMMXF

RNS Number : 8924S

Canaccord Genuity Limited

14 March 2019

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Name of exempt principal trader:                                                   Canaccord Genuity Limited 
 (b) Name of offeror/offeree in relation to whose relevant securities this form         MedicX Fund Limited 
 relates: 
 Use a separate form for each offeror/offeree 
                                                                                       ------------------------------- 
 (c) Name of the party to the offer with which exempt principal trader is connected:    Connected party to the Offeree 
                                                                                       ------------------------------- 
 (d) Date dealing undertaken:                                                           13 March 2019 
                                                                                       ------------------------------- 
 (e) Has the EPT previously disclosed, or is it today disclosing, under the Code in     No 
 respect 
 of any other party to this offer? 
                                                                                       ------------------------------- 
 
   2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER 
   (a)        Purchases and sales 
 
   Class of relevant      Purchases/ sales       Total number of       Highest price per unit   Lowest price per unit 
        security                                   securities              paid/received            paid/received 
 
       Ordinry NPV         Buy                       287,773                    96.4p                    95.6p 
                            Sell                       6,326                    95.86p                   95.86p 
                         -----------------  ------------------------  -----------------------  ----------------------- 
 
   (b)        Derivatives transactions (other than options) 
 
    Class of relevant       Product description      Nature of dealing         Number of reference      Price per unit 
         security                 e.g. CFD         e.g. opening/closing a           securities 
                                                    long/short position, 
                                                   increasing/reducing a 
                                                    long/short position 
 
 
   (c)        Options transactions in respect of existing securities 
   (i)         Writing, selling, purchasing or varying 
 
   Class of       Product        Writing,      Number of       Exercise          Type       Expiry date   Option money 
   relevant     description    purchasing,     securities      price per         e.g.                        paid/ 
   security      e.g. call       selling,       to which         unit         American,                   received per 
                   option      varying etc.      option                        European                       unit 
                                                relates                          etc. 
 
 
   (ii)        Exercising 
 
 Class of relevant security   Product description   Number of securities   Exercise price per unit 
                                e.g. call option 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant security         Nature of dealing          Details   Price per unit (if applicable) 
                               e.g. subscription, conversion 
 
 

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

   3.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the exempt principal trader making the disclosure and any party 
  to the offer or any person acting in concert with a party to the offer: 
  If there are no such agreements, arrangements or understandings, state "none" 
 NONE 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the exempt 
  principal trader making the disclosure and any other person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
 NONE 
 
 
 Date of disclosure:    14 March 2019 
 Contact name:          Sam Holland 
                       -------------- 
 Telephone number:      020 7523 8337 
                       -------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [e-mail]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on [phone].

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

FEREAEDLFLDNEFF

(END) Dow Jones Newswires

March 14, 2019 06:44 ET (10:44 GMT)